 | • レポートコード：QYR2104Z2685 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、頭頸部がん治療薬/治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線療法、化学療法、免疫療法）、用途別市場規模（病院、パーソナルケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・頭頸部がん治療薬/治療の市場動向 ・企業の競争状況、市場シェア ・頭頸部がん治療薬/治療の種類別市場規模（手術、放射線療法、化学療法、免疫療法） ・頭頸部がん治療薬/治療の用途別市場規模（病院、パーソナルケア） ・頭頸部がん治療薬/治療の北米市場規模2016-2027（アメリカ、カナダ） ・頭頸部がん治療薬/治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・頭頸部がん治療薬/治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・頭頸部がん治療薬/治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・頭頸部がん治療薬/治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Eli Lilly、Amgen、Actavis、Dr. Reddy’s Laboratories、Jiangsu Hengrui、Teva Pharmaceutical、DFG、BioXpress） ・結論 |
Market Analysis and Insights: Global Head and Neck Cancer Drugs/Therapeutics Market
The global Head and Neck Cancer Drugs/Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Head and Neck Cancer Drugs/Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Head and Neck Cancer Drugs/Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Head and Neck Cancer Drugs/Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Head and Neck Cancer Drugs/Therapeutics market.
Global Head and Neck Cancer Drugs/Therapeutics Scope and Market Size
Head and Neck Cancer Drugs/Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Head and Neck Cancer Drugs/Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgery
Radiation therapy
Chemotherapy
Immunotherapy
Segment by Application
Hospital
Personal Care
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi
Eli Lilly
Amgen
Actavis
Dr. Reddy’s Laboratories
Jiangsu Hengrui
Teva Pharmaceutical
DFG
BioXpress
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Head and Neck Cancer Drugs/Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Radiation therapy
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.3 Market by Application
1.3.1 Global Head and Neck Cancer Drugs/Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Personal Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Head and Neck Cancer Drugs/Therapeutics Market Perspective (2016-2027)
2.2 Head and Neck Cancer Drugs/Therapeutics Growth Trends by Regions
2.2.1 Head and Neck Cancer Drugs/Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Head and Neck Cancer Drugs/Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Head and Neck Cancer Drugs/Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Head and Neck Cancer Drugs/Therapeutics Industry Dynamic
2.3.1 Head and Neck Cancer Drugs/Therapeutics Market Trends
2.3.2 Head and Neck Cancer Drugs/Therapeutics Market Drivers
2.3.3 Head and Neck Cancer Drugs/Therapeutics Market Challenges
2.3.4 Head and Neck Cancer Drugs/Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Head and Neck Cancer Drugs/Therapeutics Players by Revenue
3.1.1 Global Top Head and Neck Cancer Drugs/Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Head and Neck Cancer Drugs/Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Head and Neck Cancer Drugs/Therapeutics Revenue
3.4 Global Head and Neck Cancer Drugs/Therapeutics Market Concentration Ratio
3.4.1 Global Head and Neck Cancer Drugs/Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Head and Neck Cancer Drugs/Therapeutics Revenue in 2020
3.5 Head and Neck Cancer Drugs/Therapeutics Key Players Head office and Area Served
3.6 Key Players Head and Neck Cancer Drugs/Therapeutics Product Solution and Service
3.7 Date of Enter into Head and Neck Cancer Drugs/Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Head and Neck Cancer Drugs/Therapeutics Breakdown Data by Type
4.1 Global Head and Neck Cancer Drugs/Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Head and Neck Cancer Drugs/Therapeutics Forecasted Market Size by Type (2022-2027)
5 Head and Neck Cancer Drugs/Therapeutics Breakdown Data by Application
5.1 Global Head and Neck Cancer Drugs/Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Head and Neck Cancer Drugs/Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Head and Neck Cancer Drugs/Therapeutics Market Size (2016-2027)
6.2 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Type
6.2.1 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2027)
6.3 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Application
6.3.1 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2027)
6.4 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Country
6.4.1 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Head and Neck Cancer Drugs/Therapeutics Market Size (2016-2027)
7.2 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Type
7.2.1 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2027)
7.3 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Application
7.3.1 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2027)
7.4 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Country
7.4.1 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Type
8.2.1 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Application
8.3.1 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Region
8.4.1 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size (2016-2027)
9.2 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Type
9.2.1 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Application
9.3.1 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Country
9.4.1 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Type
10.2.1 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Application
10.3.1 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Country
10.4.1 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Head and Neck Cancer Drugs/Therapeutics Introduction
11.1.4 Sanofi Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Head and Neck Cancer Drugs/Therapeutics Introduction
11.2.4 Eli Lilly Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Head and Neck Cancer Drugs/Therapeutics Introduction
11.3.4 Amgen Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Actavis
11.4.1 Actavis Company Details
11.4.2 Actavis Business Overview
11.4.3 Actavis Head and Neck Cancer Drugs/Therapeutics Introduction
11.4.4 Actavis Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
11.4.5 Actavis Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Company Details
11.5.2 Dr. Reddy’s Laboratories Business Overview
11.5.3 Dr. Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Introduction
11.5.4 Dr. Reddy’s Laboratories Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 Jiangsu Hengrui
11.6.1 Jiangsu Hengrui Company Details
11.6.2 Jiangsu Hengrui Business Overview
11.6.3 Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Introduction
11.6.4 Jiangsu Hengrui Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
11.6.5 Jiangsu Hengrui Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Introduction
11.7.4 Teva Pharmaceutical Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
11.7.5 Teva Pharmaceutical Recent Development
11.8 DFG
11.8.1 DFG Company Details
11.8.2 DFG Business Overview
11.8.3 DFG Head and Neck Cancer Drugs/Therapeutics Introduction
11.8.4 DFG Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
11.8.5 DFG Recent Development
11.9 BioXpress
11.9.1 BioXpress Company Details
11.9.2 BioXpress Business Overview
11.9.3 BioXpress Head and Neck Cancer Drugs/Therapeutics Introduction
11.9.4 BioXpress Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
11.9.5 BioXpress Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Head and Neck Cancer Drugs/Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Radiation therapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Immunotherapy
Table 6. Global Head and Neck Cancer Drugs/Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Head and Neck Cancer Drugs/Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Head and Neck Cancer Drugs/Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Head and Neck Cancer Drugs/Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Head and Neck Cancer Drugs/Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Head and Neck Cancer Drugs/Therapeutics Market Share by Regions (2022-2027)
Table 12. Head and Neck Cancer Drugs/Therapeutics Market Trends
Table 13. Head and Neck Cancer Drugs/Therapeutics Market Drivers
Table 14. Head and Neck Cancer Drugs/Therapeutics Market Challenges
Table 15. Head and Neck Cancer Drugs/Therapeutics Market Restraints
Table 16. Global Head and Neck Cancer Drugs/Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Head and Neck Cancer Drugs/Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Head and Neck Cancer Drugs/Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Head and Neck Cancer Drugs/Therapeutics as of 2020)
Table 19. Ranking of Global Top Head and Neck Cancer Drugs/Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Head and Neck Cancer Drugs/Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Head and Neck Cancer Drugs/Therapeutics Product Solution and Service
Table 23. Date of Enter into Head and Neck Cancer Drugs/Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Head and Neck Cancer Drugs/Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Head and Neck Cancer Drugs/Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Head and Neck Cancer Drugs/Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Head and Neck Cancer Drugs/Therapeutics Product
Table 66. Sanofi Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Head and Neck Cancer Drugs/Therapeutics Product
Table 71. Eli Lilly Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. Amgen Company Details
Table 74. Amgen Business Overview
Table 75. Amgen Head and Neck Cancer Drugs/Therapeutics Product
Table 76. Amgen Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. Actavis Company Details
Table 79. Actavis Business Overview
Table 80. Actavis Head and Neck Cancer Drugs/Therapeutics Product
Table 81. Actavis Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Actavis Recent Development
Table 83. Dr. Reddy’s Laboratories Company Details
Table 84. Dr. Reddy’s Laboratories Business Overview
Table 85. Dr. Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Product
Table 86. Dr. Reddy’s Laboratories Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Dr. Reddy’s Laboratories Recent Development
Table 88. Jiangsu Hengrui Company Details
Table 89. Jiangsu Hengrui Business Overview
Table 90. Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Product
Table 91. Jiangsu Hengrui Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Jiangsu Hengrui Recent Development
Table 93. Teva Pharmaceutical Company Details
Table 94. Teva Pharmaceutical Business Overview
Table 95. Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Product
Table 96. Teva Pharmaceutical Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Teva Pharmaceutical Recent Development
Table 98. DFG Company Details
Table 99. DFG Business Overview
Table 100. DFG Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021) & (US$ Million)
Table 101. DFG Recent Development
Table 102. BioXpress Company Details
Table 103. BioXpress Business Overview
Table 104. BioXpress Head and Neck Cancer Drugs/Therapeutics Product
Table 105. BioXpress Revenue in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021) & (US$ Million)
Table 106. BioXpress Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Head and Neck Cancer Drugs/Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Radiation therapy Features
Figure 4. Chemotherapy Features
Figure 5. Immunotherapy Features
Figure 6. Global Head and Neck Cancer Drugs/Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Personal Care Case Studies
Figure 9. Head and Neck Cancer Drugs/Therapeutics Report Years Considered
Figure 10. Global Head and Neck Cancer Drugs/Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Head and Neck Cancer Drugs/Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Head and Neck Cancer Drugs/Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Head and Neck Cancer Drugs/Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Head and Neck Cancer Drugs/Therapeutics Market Share by Players in 2020
Figure 15. Global Top Head and Neck Cancer Drugs/Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Head and Neck Cancer Drugs/Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Head and Neck Cancer Drugs/Therapeutics Revenue in 2020
Figure 17. Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Head and Neck Cancer Drugs/Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Head and Neck Cancer Drugs/Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Head and Neck Cancer Drugs/Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Head and Neck Cancer Drugs/Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Head and Neck Cancer Drugs/Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Head and Neck Cancer Drugs/Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Head and Neck Cancer Drugs/Therapeutics Market Share by Region (2016-2027)
Figure 39. China Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Head and Neck Cancer Drugs/Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Head and Neck Cancer Drugs/Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Head and Neck Cancer Drugs/Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Head and Neck Cancer Drugs/Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Sanofi Revenue Growth Rate in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
Figure 61. Actavis Revenue Growth Rate in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
Figure 62. Dr. Reddy’s Laboratories Revenue Growth Rate in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
Figure 63. Jiangsu Hengrui Revenue Growth Rate in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
Figure 65. DFG Revenue Growth Rate in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
Figure 66. BioXpress Revenue Growth Rate in Head and Neck Cancer Drugs/Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の頭頸部がん治療市場規模・現状・予測（2021年-2027年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…- 世界の頭頸部がん診断市場規模・現状・予測（2021年-2027年） Head and neck cancer begins in squamous cells that line the mucosal surfaces of the head and neck such as, inside the mouth, the nose, and the throat. The head and neck cancers include specific areas of the body such as oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary g…
- 世界のがん治療・支持療法薬市場 2021：企業別、地域別、種類・用途別 The Cancer Therapeutics and Supportive Care Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 世界の頭頸部扁平上皮がん（HNSCC）治療市場規模・現状・予測（2021年-2027年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…
- 世界の肝臓がん治療市場規模・現状・予測（2021年-2027年） Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the ri…